Speaking from the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Paul O'Toole, PhD, from the University College Cork, Cork, Ireland, discusses the role of the gut microbiome as a promising and targetable risk factor for colorectal cancer (CRC). Prof. O'Toole not only highlights the microbial community within the gut as a potential diagnostic tool for CRC, but also as a modifiable modulator of cancer immunotherapy.
